Patents by Inventor Misty D. Rowe

Misty D. Rowe has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Gold/lanthanide nanoparticle conjugates and uses thereof
    Patent number: 10406111
    Abstract: The present disclosure is directed generally to gold/lanthanide nanoparticle conjugates, such as gold/gadolinium nanoparticle conjugates, nanoparticle conjugates including polymers, nanoparticle conjugates conjugated to targeting agents and therapeutic agents, and their use in targeting, treating, and/or imaging disease states in a patient.
    Type: Grant
    Filed: March 3, 2015
    Date of Patent: September 10, 2019
    Assignee: Colorado School of Mines
    Inventors: Stephen G. Boyes, Misty D. Rowe
  • Gold nanoparticle conjugates and uses thereof
    Patent number: 9382346
    Abstract: The disclosure generally relates to formation of polymers grafted to or polymerized from the surface of gold nanoparticles. The polymers are functionalized to include therapeutic agents and/or targeting agents at their surface, thereby allowing both therapeutic and targeting compounds to be directed to specific cells in a patient.
    Type: Grant
    Filed: September 28, 2015
    Date of Patent: July 5, 2016
    Assignee: COLORADO SCHOOL OF MINES
    Inventors: Stephen G. Boyes, Misty D. Rowe, Jay Hotchkiss
  • Gold Nanoparticle Conjugates and Uses Thereof
    Publication number: 20160017065
    Abstract: The disclosure generally relates to formation of polymers grafted to or polymerized from the surface of gold nanoparticles. The polymers are functionalized to include therapeutic agents and/or targeting agents at their surface, thereby allowing both therapeutic and targeting compounds to be directed to specific cells in a patient.
    Type: Application
    Filed: September 28, 2015
    Publication date: January 21, 2016
    Inventors: Stephen G. Boyes, Misty D. Rowe, Jay Hotchkiss
  • Gold nanoparticle conjugates and uses thereof
    Patent number: 9175015
    Abstract: The disclosure generally relates to formation of polymers grafted to or polymerized from the surface of gold nanoparticles. The polymers are functionalized to include therapeutic agents and/or targeting agents at their surface, thereby allowing both therapeutic and targeting compounds to be directed to specific cells in a patient.
    Type: Grant
    Filed: August 22, 2008
    Date of Patent: November 3, 2015
    Assignee: COLORADO SCHOOL OF MINES
    Inventors: Stephen G. Boyes, Misty D. Rowe, Jay Hotchkiss
  • Lanthanide Nanoparticle Conjugates and Uses Thereof
    Publication number: 20150306256
    Abstract: The present disclosure is directed generally to lanthanide nanoparticle conjugates, such as gadolinium nanoparticle conjugates, nanoparticle conjugates including polymers, conjugation to targeting agents and therapeutic agents, and their use in targeting, treating, and/or imaging disease states in a patient.
    Type: Application
    Filed: December 23, 2014
    Publication date: October 29, 2015
    Inventors: Stephen G. Boyes, Misty D. Rowe, Douglas H. Thamm, Susan L. Kraft
  • GOLD/LANTHANIDE NANOPARTICLE CONJUGATES AND USES THEREOF
    Publication number: 20150258034
    Abstract: The present disclosure is directed generally to gold/lanthanide nanoparticle conjugates, such as gold/gadolinium nanoparticle conjugates, nanoparticle conjugates including polymers, nanoparticle conjugates conjugated to targeting agents and therapeutic agents, and their use in targeting, treating, and/or imaging disease states in a patient.
    Type: Application
    Filed: March 3, 2015
    Publication date: September 17, 2015
    Inventors: Stephen G. Boyes, Misty D. Rowe
  • Gold/lanthanide nanoparticle conjugates and uses thereof
    Patent number: 8968705
    Abstract: The present disclosure is directed generally to gold/lanthanide nanoparticle conjugates, such as gold/gadolinium nanoparticle conjugates, nanoparticle conjugates including polymers, nanoparticle conjugates conjugated to targeting agents and therapeutic agents, and their use in targeting, treating, and/or imaging disease states in a patient.
    Type: Grant
    Filed: February 17, 2010
    Date of Patent: March 3, 2015
    Assignee: Colorado School of Mines
    Inventors: Stephen G. Boyes, Misty D. Rowe
  • Lanthanide nanoparticle conjugates and uses thereof
    Patent number: 8916135
    Abstract: The present disclosure is directed generally to lanthanide nanoparticle conjugates, such as gadolinium nanoparticle conjugates, nanoparticle conjugates including polymers, conjugation to targeting agents and therapeutic agents, and their use in targeting, treating, and/or imaging disease states in a patient.
    Type: Grant
    Filed: August 22, 2008
    Date of Patent: December 23, 2014
    Assignees: Colorado School of Mines, Colorado State University Research Foundation
    Inventors: Stephen G. Boyes, Misty D. Rowe, Douglas H. Thamm, Susan L. Kraft
  • GOLD/LANTHANIDE NANOPARTICLE CONJUGATES AND USES THEREOF
    Publication number: 20120052006
    Abstract: The present disclosure is directed generally to gold/lanthanide nanoparticle conjugates, such as gold/gadolinium nanoparticle conjugates, nanoparticle conjugates including polymers, nanoparticle conjugates conjugated to targeting agents and therapeutic agents, and their use in targeting, treating, and/or imaging disease states in a patient.
    Type: Application
    Filed: February 17, 2010
    Publication date: March 1, 2012
    Applicant: COLORADO SCHOOL OF MINES
    Inventors: Stephen G. Boyes, Misty D. Rowe
  • Gold Nanoparticle Conjugates and Uses Thereof
    Publication number: 20090060839
    Abstract: The disclosure generally relates to formation of polymers grafted to or polymerized from the surface of gold nanoparticles. The polymers are functionalized to include therapeutic agents and/or targeting agents at their surface, thereby allowing both therapeutic and targeting compounds to be directed to specific cells in a patient.
    Type: Application
    Filed: August 22, 2008
    Publication date: March 5, 2009
    Inventors: Stephen G. Boyes, Misty D. Rowe, Jay Hotchkiss
  • Lanthanide Nanoparticle Conjugates and Uses Thereof
    Publication number: 20090060840
    Abstract: The present disclosure is directed generally to lanthanide nanoparticle conjugates, such as gadolinium nanoparticle conjugates, nanoparticle conjugates including polymers, conjugation to targeting agents and therapeutic agents, and their use in targeting, treating, and/or imaging disease states in a patient.
    Type: Application
    Filed: August 22, 2008
    Publication date: March 5, 2009
    Inventors: Stephen G. Boyes, Misty D. Rowe, Douglas H. Thamm, Susan L. Kraft